Market leadership Fingerpaint Medical operates in healthcare advertising services with a focus on translating clinical evidence into practice, presenting opportunities to position services as essential for pharma and biotech clients seeking faster product adoption and competitive differentiation.

Growth momentum Recent leadership promotions and new executive hires, including a Chief Technology & Product Officer and a General Manager, signal strong growth and a willingness to invest in strategic capabilities that can be leveraged to offer expanded consulting, tech-enabled marketing, and integrated medical communications services.

Digital & tech stack Adoption of tools like Decideware, DoubleVerify, Mediaocean, SAP, .NET and analytics platforms indicates readiness to deliver data-driven campaigns, attribution, and digital program management—opportunities to offer advanced analytics, tech-enabled workflow optimization, and verification services to clients.

Commercial expansion Launch of a commercial support program for a rare brain cancer therapy shows Fingerpaint’s ability to scale market access and patient transition programs, suggesting upsell potential to pharma clients needing launch readiness, payer strategy, and access communications.

Industry recognition Recognition as Manny Awards finalists and ongoing leadership announcements reflect credibility and momentum, making a compelling case to approach prospective pharma/biotech clients with proven success in strategic communications and medical education across competitive therapeutic areas.